Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Net Income towards Common Stockholders (2024 - 2025)

Historic Net Income towards Common Stockholders for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$32.8 million.

  • Kestra Medical Technologies' Net Income towards Common Stockholders fell 3838.59% to -$32.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$138.8 million, marking a year-over-year decrease of 4817.17%. This contributed to the annual value of -$126.1 million for FY2025, which is 2508.31% down from last year.
  • Per Kestra Medical Technologies' latest filing, its Net Income towards Common Stockholders stood at -$32.8 million for Q4 2025, which was down 3838.59% from -$25.8 million recorded in Q3 2025.
  • In the past 5 years, Kestra Medical Technologies' Net Income towards Common Stockholders ranged from a high of -$22.3 million in Q3 2024 and a low of -$55.3 million during Q2 2025